News Focus
News Focus
icon url

fluteman

05/22/21 8:28 AM

#38104 RE: sab63090 #38103

ASM email:



Dear Invest Client,

You elected to receive shareholder communications and submit voting instructions via the Internet. This e-mail notification contains information specific to your holding(s) in the security identified below.


Please read the instructions carefully before proceeding.

Important Notice Regarding the Availability of Proxy Materials for the
Shareholder Meeting
2021 CEL-SCI CORPORATION Annual Meeting of Stockholders
MEETING DATE: July 1, 2021

CUSIP NUMBER: 150837607
icon url

Biobonic

05/22/21 8:44 AM

#38105 RE: sab63090 #38103

Submitting to the FDA

This post will be totally and completely my viewpoint.

I have no links to back up what I think.

Either way, whether with supportive links or not, my thinking may be totally off base.

IMO - Geert was showing the FDA respect by submitting before announcing.

(A good thing when one considers the 2016 - "I'm going to add some more patients to the trail" fiasco.)

IMO - The FDA has no mechanism to 'accept' the CSR without a Marketing Application. (BLA in CVM's situation)

IMO - Therefore the FDA will not receive it prior.


Again - In my opinion.